The Patent Finder

Therabron Therapeutics, Inc.

Also on record
Records under this name other than the patents Therabron Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.

Showing 1 to 7 of 7 · Back to Therabron Therapeutics, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,294,285Modification and Compositions of Human Secretoglobin Proteins
Held by another company
In force
 · High confidence
In forceHigh confidence
US 10,556,938Compositions and Methods of Use for Recombinant Human Secretoglobins
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,676,513Modification and Compositions of Human Secretoglobin Proteins
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,168,285Recombinant Human CC10 Protein for Treatment of Influenza and Ebola
Lapsed on the fee record
Ended Oct 27, 2023 · Medium confidence
Lapsed on the fee recordEnded Oct 27, 2023Medium confidence
US 7,122,344Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions
Term ended
Term ended Sep 22, 2017 · USPTO record
Term endedTerm ended Sep 22, 2017USPTO record
US 6,255,281Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
Term ended
Term ended May 28, 2017 · USPTO record
Term endedTerm ended May 28, 2017USPTO record
US 7,846,899Methods and compositions for the reduction of neutrophil influx and for the treatment of bronchpulmonary dysplasia, respiratory distress syndrome, chronic lung disease, pulmonary fibrosis, asthma and chronic obstructive pulmonary disease
Term ended
Term ended May 28, 2017 · USPTO record
Term endedTerm ended May 28, 2017USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited